Airsoft guns can cause permanent ocular damage in children

Article

Airsoft guns can cause ocular damage that requires operative intervention.

Airsoft guns can cause ocular damage that requires operative intervention, claims a study in the Journal of Pediatric Ophthalmology and Strabismus.

Dr Tarek A. Shazly et al., Department of Ophthalmology, Assiut University Hospital, Assiut, Egypt, conducted a retrospective chart review on 32 paediatric patients who suffered ocular injuries from using airsoft guns between November 2005 and December 2007. Place of trauma, presenting symptoms and signs, surgical interventions and final visual outcome were assessed in each patient.

Of the patients studied, 24 presented with hyphaema, 10 had corneal abrasions and 7 experienced raised intraocular pressure. Immediate surgical intervention was required in 7 patients and 7 patients underwent elective surgery.

In 5 patients final visual acuity was 20/200 or worse, 23 patients had 20/40 or better and 2 patients could not be assessed.

There is significant long-term morbidity from some of the ocular injuries examined in the study. It was concluded that airsoft guns can cause a variety of ocular disorders - both serious and permanent.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.